$220.9 million cash and cash equivalents as of June 30, 2025 supports cash runway through 2027, including multiple clinical inflection points SAN FRANCISCO and VANCOUVER, British Columbia, Aug. 13, ...

How did Jade Bird Fire Alarm's performance compare year-over-year in the latest quarter? The company's revenue moved from 1,267.20 in the previous quarter to 1,208.66 in the latest quarter, and net ...

Jade Biosciences, Inc. (Nasdaq: JBIO), a biotechnology company focused on autoimmune disease therapies, has announced the successful completion of its reverse merger and its debut on Nasdaq, along ...

Presented favorable preclinical safety data for JADE101 and a translational analysis of APRIL mediated biomarker responses at the American Society of Nephrology Kidney Week 2025, reinforcing its ...

Presented preclinical data for JADE101 at the 62nd European Renal Association Congress, highlighting its potential as a best-in-class anti-APRIL monoclonal antibody for IgA nephropathy Phase 1 healthy ...